Cabozantinib selectively induces proteasomal degradation of p53 somatic mutant Y220C and impedes tumor growth - Fang Lin Lv; Lu Zhang; Cheng Ji; Lei Peng; Mingxian Zhu; Shumin Yang; Shunli Dong; Mingxuan Zhou; Fanfan Guo; Zhenyun Li; Fang Wang; Youguo Chen; et al. (Journal of Biological Chemistry, 2025)